Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1263 |
---|---|
Product Name | Anti-Human ITGA2 Recombinant Antibody |
Molecular Name | Vatelizumab |
Alias | Anti-ITGA2 Recombinant Antibody, Research Grade Vatelizumab |
CAS Number | 1238217-55-4 |
Target | ITGA2[Homo sapiens] |
Isotype | IgG4 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | WB, IF, IP, Neut, FuncS, ELISA, FCM |
Buffer | PBS, pH7.5 |
Background | Vatelizumab is an immunomodulator. It binds to integrin alpha 2. It was withdrawn from Phase II trials for inflammatory bowel disease due to a lack of efficacy. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |